Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

SOLID BIOSCIENCES INC.

(SLDB)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
06/16/2021 06/17/2021 06/18/2021 06/21/2021 06/22/2021 Date
3.94(c) 4.06(c) 3.91(c) 3.86(c) 3.77(c) Last
791 212 743 417 1 452 155 692 977 998 886 Volume
-2.23% +3.05% -3.69% -1.28% -2.33% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 5,83 M - -
Net income 2021 -80,4 M - -
Net cash position 2021 189 M - -
P/E ratio 2021 -4,95x
Yield 2021 -
Sales 2022 9,58 M - -
Net income 2022 -91,7 M - -
Net cash position 2022 116 M - -
P/E ratio 2022 -5,08x
Yield 2022 -
Capitalization 416 M 416 M -
EV / Sales 2021 39,0x
EV / Sales 2022 31,3x
Nbr of Employees 70
Free-Float 75,0%
More Financials
Company
Solid Biosciences Inc., formerly Solid Biosciences, LLC, is a life science company. The Company is focused on developing therapies for duchenne muscular dystrophy (DMD). It is developing gene therapies, disease modifying therapies and assistive devices, all targeting the various facets of the DMD. Its corrective therapies platform is engaged in the development of gene therapy candidates for DMD. Its lead program,... 
More about the company
Ratings of Solid Biosciences Inc.
Trading Rating : 
Investor Rating :  -
ESG Refinitiv : 
D+
More Ratings
All news about SOLID BIOSCIENCES INC.
06/17SOLID BIOSCIENCESá : AMENDMENT NO. 1 TO 2020 STOCK INCENTIVE PLAN (Form 8-K)
PU
06/17SOLID BIOSCIENCES INC.á : Change in Directors or Principal Officers, Submission ..
AQ
06/16SOLID BIOSCIENCES INC.á : Entry into a Material Definitive Agreement, Creation o..
AQ
06/09SOLID BIOSCIENCESá : Thinking about buying stock in Aethlon Medical, Checkpoint ..
PR
06/07Solid Biosciences Reports Inducement Grant to New Chief Regulatory Officer
GL
06/07Solid Biosciences Announces Appointment of Iman Barilero, PharmD, Ph.D., as C..
GL
05/27SOLID BIOSCIENCESá : Jefferies Starts Solid Biosciences at Buy With $7 Price Tar..
MT
05/26Solid Biosciences to Present at the Jefferies Virtual Healthcare Conference
GL
05/25Solid Biosciences to Present at Upcoming Scientific Conferences
GL
05/17SOLID BIOSCIENCESá : Barclays Adjusts Price Target on Solid Biosciences to $8 Fr..
MT
05/14SECTOR UPDATE : Health Care Stocks Rise Friday But Trail Most Other Sectors
MT
05/14SOLID BIOSCIENCESá : Tumbles After Duchenne's Patient Experiences Adverse Initia..
MT
05/14SOLID BIOSCIENCESá : Q1 Loss Narrows, Says Cash Sufficient to Fund Business Into..
MT
05/14SOLID BIOSCIENCES INC.á : Results of Operations and Financial Condition, Financi..
AQ
05/14SOLID BIOSCIENCESá : Management's Discussion and Analysis of Financial Condition..
AQ
More news
News in other languages on SOLID BIOSCIENCES INC.

- No features available -

More news
Analyst Recommendations on SOLID BIOSCIENCES INC.
More recommendations
Chart SOLID BIOSCIENCES INC.
Duration : Period :
Solid Biosciences Inc. Technical Analysis Chart | SLDB | US83422E1055 | MarketScreener
Technical analysis trends SOLID BIOSCIENCES INC.
Short TermMid-TermLong Term
TrendsNeutralBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 7
Last Close Price 3,77 $
Average target price 9,14 $
Spread / Average Target 143%
EPS Revisions
Managers and Directors
NameTitle
Ilan Ganot President, Chief Executive Officer & Director
Stephen J. DiPalma Chief Financial Officer & Treasurer
Ian Frederick Smith Chairman
Carl Morris Chief Scientific Officer
Cathryn M. Clary Chief Medical Officer
Sector and Competitors
1st jan.Capitalization (M$)
SOLID BIOSCIENCES INC.-50.26%426
GILEAD SCIENCES, INC.15.09%84 469
WUXI APPTEC CO., LTD.24.70%66 143
REGENERON PHARMACEUTICALS10.54%55 327
BIONTECH SE190.10%54 605
VERTEX PHARMACEUTICALS-20.09%48 589